Crystalline forms
US-11053201-B2 · Jul 6, 2021 · US
USRE50724E · US · E1
| Field | Value |
|---|---|
| Publication number | US-RE50724-E |
| Application number | US-201418112640-A |
| Country | US |
| Kind code | E1 |
| Filing date | Jul 1, 2014 |
| Priority date | Jul 8, 2013 |
| Publication date | Jan 6, 2026 |
| Grant date | Jan 6, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of the formula (I), in which the substituents are as defined in claim 1 , are suitable for use as nematicides.
Opening claim text (preview).
The invention claimed is: 1 . A compound selected from 2 . A composition, comprising: a compound of formula (I) selected from wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 3 . AThe compound according to claim 1 which is, wherein the compound is 4 . AThe compound according to claim 1 which is, wherein the compound is 5 . AThe compound according to claim 1 which is, wherein the compound is 6 . AThe compound according to claim 1 which is, wherein the compound is 7 . AThe composition according to claim 2 comprising a compound of formula, wherein the compound of formula (I) is wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 8 . AThe composition according to claim 2 comprising a compound of formula, wherein the compound of formula (I) is wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 9 . AThe composition according to claim 2 comprising a compound of formula, wherein the compound of formula (I) is wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 10 . AThe composition according to claim 2 comprising a compound of formula, wherein the compound of formula (I) is wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 11 . A composition according to claim 2 comprising a compound of formula wherein the ratio of the compound of formula (I) to its enantiomer is greater than 1.5:1, greater than 2.5:1, greater than 4:1, greater than 9:1, or greater than 20:1. 12 . The composition according to claim 2 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 9:1. 13 . A method of controlling pests in soil, the method comprising: applying to the soil a composition according to claim 12 . 14 . The method of claim 13 , wherein the application to the soil is through a solid carrier treated with the composition. 15 . The method of claim 14 , wherein the solid carrier is a seed. 16 . The method of claim 13 , wherein the pest is a nematode. 17 . The composition ofaccording to claim 2 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 20:1. 18. The composition according to claim 8 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 2.5:1. 19. The composition according to claim 8 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 4:1. 20. The composition according to claim 8 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 9:1. 21. The composition according to claim 8 , wherein the ratio of the compound of formula (I) to its enantiomer is greater than 20:1. 22. The composition according to claim 8 , wherein the composition is free of the enantiomer of the compound of formula (I). 23. The composition according to claim 19 , further comprising a second compound that is a biological active agent. 24. The composition of claim 23 , the second compound is selected from an acaricide, an algicide, a bactericide, a biological agent, an insect repellant, a nematicide, a mollusicide, or a fungicide. 25. The composition of claim 23 , wherein the second compound is selected from azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, pefurazoate, penconazole, prothioconazole, pyrifenox, prochloraz, propiconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole, ancymidol, fenarimol, nuarimol, bupirimate, dimethirimol, ethirimol, dodemorph, fenpropidine, fenpropimorph, spiroxamine, tridemorph, cyprodinil, mepanipyrim, pyrimethanil, fenpiclonil, fludioxonil, benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofurace, oxadixyl, benomyl, carbendazim, debacarb, fuberidazole, thiabendazole, chlozolinate, dichlozoline, iprodione, myclozoline, procymidone, vinclozoline, boscalid, carboxin, fenfuram, flutolanil, mepronil, oxycarboxin, penthiopyrad, thifluzamide, guazatine, dodine, iminoctadine, azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, orysastrobin, picoxystrobin, pyraclostrobin, ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram, captafo, captan, dichlofluanid, fluoroimide, folpet, tolylfluanid, bordeaux mixture, copperhydroxid, copperoxychlorid, coppersulfat, copperoxid, mancopper, oxine-copper, dinocap, nitrothal-isopropyl, edifenphos, iprobenphos, isoprothiolane, phosdiphen, pyrazophos, tolclofosmethyl, acibenzolar-S-methyl, anilazine, benthiavalicarb, blasticidin-S, chinomethionat, chloroneb, chlorothalonil, cyflufenamid, cymoxanil, dichlone, diclocymet, diclomezine, dicloran, diethofencarb, dimethomorph, SYP-L190 (Flumorph), dithianon, ethaboxam, etridiazole, famoxadone, fenamidone, fenoxanil, fentin, ferimzone, fluazinam, fluopicolide, flusulfamide, fenhexamid, fosetyl-aluminium, hymexazol, iprovalicarb, IKF-916 (Cyazofamid), kasugamycin, methasulfocarb, metrafenone, pencycuron, phthalide, polyoxins, probenazole, propamocarb, proquinazid, pyroquilon, quinoxyfen, quintozene, sulphur, tiadinil, triazoxide, tricyclazole, triforine, validamycin, zoxamide (RH7281), mandipropamid, isopyrazam, sedaxane, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid [2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-amide, 1-[4-[4-[(5S)5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl]piperidin-1-yl]-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, 1-[4-[4-[5-(2,6-difluorophenyl)-
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring atoms · CPC title
condensed with carbocyclic rings or ring systems · CPC title
in position 3 · CPC title
having isocyanate groups bound to carbon atoms of rings other than six-membered aromatic rings · CPC title
with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.